The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists

The presented expert paper discusses the high prevalence of hypercholesterolemia (HCH) in Russia. Insufficient use of lipid-lowering therapy in both primary and secondary prevention is indicated. Failure to achieve the target level of low-density lipoprotein cholesterol (HC) and low adherence (espec...

Descripción completa

Detalles Bibliográficos

Autores principales:	Marina G. Bubnova, Albert S. Galyаvich, Marat V. Ezhov, David M. Aronov, Natalia N. Vinogradova, Gagik R. Galstyan, Viktor S Gurevich, Yuri A. Karpov, Natalia A. Koziolova, Elena D. Kosmacheva, Gennady V. Matyushin, Igor V. Sergienko, Alexander E. Philippov, Iurii Sh. Khalimov
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Concilium Medicum 2025-01-01
Colección:	КардиоСоматика
Materias:	atherosclerosis cardiovascular diseases prevention lipid-lowering therapy statins pitavastatin
Acceso en línea:	https://cardiosomatics.ru/2221-7185/article/viewFile/676903/198223
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!